Tri-Institutional Therapeutics Discovery Institute

5 articles about Tri-Institutional Therapeutics Discovery Institute

• Schrödinger and Tri-Institutional Therapeutics Discovery Institute Renew Agreement to Provide Drug Discovery Software to Tri-Institutional Researchers

  4/12/2018

  Schrödinger, Inc. and the Tri-Institutional Therapeutics Discovery Institute, Inc.have renewed and extended, for an additional five years, an agreement reached in 2014 to provide access to Schrödinger's Materials Science, Biologics, and Small?Molecule Drug Discovery Suites to researchers within TRI-I TDI's member institutions.

• Bridge Medicines Accepts Novel Small Molecule Targeting Basal Cell Carcinoma As First Drug Candidate for Development

  3/14/2018

  Project Originated at Rockefeller University and Graduated From Tri-Institutional Therapeutics Discovery Institute

• Torrey Pines Institute for Molecular Studies And The Tri-Institutional Therapeutics Discovery Institute Announce Strategic Agreement

  7/25/2017

• Ablexis Release: Company Announces Perpetual License Of The Alivamab Mouse To Tri-Institutional Therapeutics Discovery Institute

  1/12/2017

• Charles River And The Tri-Institutional Therapeutics Discovery Institute Announce Strategic Partnership

  9/22/2016